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Mitochondrial uncoupling protein 1 (UCP1) is respon-
sible for nonshivering thermogenesis in brown
adipose tissue (BAT). Upon activation by long-chain
fatty acids (LCFAs), UCP1 increases the conduc-
tance of the inner mitochondrial membrane (IMM)
to make BAT mitochondria generate heat rather
than ATP. Despite being a member of the family of
mitochondrial anion carriers (SLC25), UCP1 is
believed to transport H+ by an unusual mechanism
that has long remained unresolved. Here, we
achieved direct patch-clamp measurements of
UCP1 currents from the IMM of BAT mitochondria.
We show that UCP1 is an LCFA anion/H+ symporter.
However, the LCFA anions cannot dissociate from
UCP1 due to hydrophobic interactions established
by their hydrophobic tails, and UCP1 effectively
operates as anH+ carrier activated by LCFA. A similar
LCFA-dependent mechanism of transmembrane
H+ transport may be employed by other SLC25
members and be responsible for mitochondrial
uncoupling and regulation of metabolic efficiency in
various tissues.INTRODUCTION
Brown adipose tissue (BAT) specializes in burning fat and is
responsible for adaptive, nonshivering thermogenesis in
mammals (Cannon and Nedergaard, 2004; Enerba¨ck et al.,
1997). The thermogenic ability of BAT is conferred by uncoupling
protein 1 (UCP1), a BAT-specific transport protein of the inner
mitochondrial membrane (IMM) (Aquila et al., 1985; Bouillaud
et al., 1986; Heaton et al., 1978; Ridley et al., 1986). UCP1
increases IMM conductance for H+ to dissipate the mitochon-
drial H+ gradient and convert the energy of substrate oxidation
into heat (Nicholls and Locke, 1984). UCP1 is activated by
long-chain fatty acids (LCFAs) that are produced within brown
adipocytes by the lipolysis of cytoplasmic lipid droplets upon
adrenergic stimulation of BAT (Cannon and Nedergaard, 2004).
Despite the importance of UCP1 for the maintenance of core400 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.body temperature and the control of energy intake and expendi-
ture balance, the LCFA-dependent mechanism of UCP1 opera-
tion remains elusive (Divakaruni and Brand, 2011; Klingenberg,
2010).
Several mechanisms of LCFA-dependent UCP1 operation
have been proposed (Figure S1A available online): (1) that of an
H+ uniporter (channel) activated by the allosteric binding of
LCFAs (Cannon and Nedergaard, 2004; Rial and Gonza´lez-
Barroso, 2001); (2) that of an OH uniporter (channel) activated
by the allosteric binding of LCFAs (Nicholls, 2006); (3) the ‘‘H+
buffering’’ model of UCP1 as an H+ channel in which LCFAs
bind to the pore and provide their carboxylic groups to complete
the H+ translocation pathway along with the titratable amino acid
residues of UCP1 (Klingenberg and Huang, 1999); and (4) the
‘‘fatty-acid cycling’’ model in which UCP1 is an LCFA anion
carrier that transports H+ indirectly: UCP1 carries LCFA anions
outside the mitochondria where they bind H+ and, in protonated
form, ‘‘flip-flop’’ back across the IMM to release the H+ into the
mitochondrial matrix (Garlid et al., 1998). Furthermore, UCP1 is
inhibited by cytosolic purine nucleotides, and the mechanism
bywhich LCFAs overcome this inhibition also remains controver-
sial (Klingenberg, 2010; Nicholls, 2006; Nicholls and Locke,
1984; Shabalina et al., 2004).
The main difficulty in determining the mechanism of UCP1
operation has been the lack of a direct method to study UCP1
transport activity in its native membrane environment. Here,
we use the patch-clamp technique to directly measure UCP1
currents in the native IMM of BAT and provide a detailed analysis
of the LCFA-dependent mechanism of UCP1 operation.
RESULTS
Identification and Biophysical Properties of UCP1
Current
To identify UCP1 currents, we applied the whole-cell patch-
clamp technique to mitoplasts (Kirichok et al., 2004), vesicles
of whole native IMM isolated from mouse BAT (Figure 1A).
In the whole-mitoplast mode, the voltage step from 0 to
160 mV, followed by a voltage ramp to +80 mV, elicited
a large-amplitude current that was strongly inhibited by the
classic UCP1 inhibitor GDP (Figure 1B) and other purine nucleo-
tides such as ATP, GTP, and ADP (data not shown). LCFAs,
classic activators of UCP1, strongly potentiated this current
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Figure 1. Electrophysiological Properties of
UCP1 Current
(A) Transmitted, fluorescent, and superimposed
images (left to right) of BAT mitoplasts isolated
from mice expressing CFP in the mitochondrial
matrix (false green color). White arrows, IMM; red
arrows, remnants of outer membrane.
(B) Whole-mitoplast putative UCP1 current before
(control, red) and after (black) the addition of 1 mM
GDP to the bath solution. The voltage protocol
is indicated at the top. The pipette-mitoplast
diagram indicates the recording conditions. The
mitoplast membrane capacitance was 1.1 pF.
(C) Putative UCP1 current (control, red) is poten-
tiated by 3 mM arachidonic acid (AA, blue) and in-
hibited by 0.25% BSA (black). The mitoplast
membrane capacitance was 1.0 pF.
(D) Representative whole-mitoplast currents re-
corded from wild-type (black) and UCP1/ (red)
mitoplasts.
(E) Current-voltage dependence of IUCP1. Ampli-
tudes were measured at the beginning of the
voltage steps shown in Figure S1D; n = 5.
(F) IUCP1 reversal potentials (Vrev) compared to H
+
equilibrium potentials (EH) predicted by the Nernst
equation. The red line indicates the linear fitting of
IUCP1 reversal potentials versusDpH; n = 3–10. The
black line indicates EH calculated by the Nernst
equation at 24C.
(G) Whole-mitoplast IUCP1 before (control, red),
after the addition of 4 mM oleoyl-CoA to the bath
solution (blue), and after the subsequent applica-
tion of 1 mM GDP (black).
(H) Left panel: IUCP1 at different symmetrical
pH values. Representative traces recorded from
different mitoplasts are shown. Right panel: Mean
IUCP1 densities in different symmetrical pH values;
n = 4–12. Amplitudes were measured upon step-
ping from 0 to 160 mV as in the left panel.
Error bars represent standard error of the mean
(SEM). See also Figure S1.(Figures 1C and S1B). Fatty-acid-free bovine serum albumin
(BSA) and alpha-cyclodextrin (aCD), which bind LCFAs and re-
move them from the membrane, strongly inhibited the observed
current (Figures 1C and S1C), suggesting that endogenous
membrane-associated LCFAs are essential for the current. The
original current observed upon breaking-in into mitoplasts and
the additional current induced by LCFAs were not present in
UCP1/ mitoplasts (n = 15; Figures 1D and S1H). Therefore,
we concluded that the LCFA-dependent, purine nucleotide-
sensitive current was mediated by UCP1. It is important toCell 151, 400–413,note that the density of the UCP1 current
is one of the highest among H+ currents
across biological membranes.
We further characterized the biophys-
ical properties of the UCP1 current
(IUCP1). At lower membrane potentials
(from 90 to +90 mV), when the ampli-
tude of IUCP1 was small, it was virtually
time independent (Figure S1D). However,as IUCP1 increased at high negative potentials (beyond 90 mV),
its amplitude declined during the voltage step (Figure S1D), likely
due to the saturation of the proton buffer inside themitoplast (see
Experimental Procedures). When IUCP1 was recorded from small
membrane patches excised from mitoplasts (inside-out mode),
no such time dependence was observed, as in this mode,
saturation of the buffer on the matrix side of the IMM is less likely
(Figure S1E). Although the inside-out IUCP1 was robust, we did
not resolve any single-channel openings, suggesting that the
amplitude of the UCP1 unitary current is very small.October 12, 2012 ª2012 Elsevier Inc. 401
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Figure 2. UCP1 Is Activated by Endogenous
Membrane LCFAs
(A) Left panel: Representative time course of IUCP1
amplitude in control (1), upon application of 0.5%
BSA (2), and with 0.5%BSA and 1mMGDP (3). AA
(5 mM) was applied at the end to verify that IUCP1
can still be activated (4). Pipette solution contained
0.5% BSA. Amplitudes were measured upon
stepping from 0 to160mV (see right panel). Right
panel: IUCP1 traces recorded at times 1, 2, 3, and 4
as indicated in the left panel.
(B) The same experiment as in (A) but performed
with 15 mM aCD in the bath and pipette solutions.
(C) Left panel: Representative time course of IUCP1
amplitude in control (1) and upon the application
(2) and subsequent washout (3) of 10 mM aCD at
pH 8.0. Right panel: IUCP1 traces recorded at times
1, 2, and 3 as indicated in the left panel.
(D) The same experiment as in (C) but performed at
symmetrical pH 6.0.
See also Figure S2.IUCP1 reversal potentials closely corresponded to the calcu-
lated H+ Nernst potentials (Figures 1F, S1F, and S1G), confirm-
ing that IUCP1 carries H
+. The UCP1 current-voltage (I/V) relation-
ship had mild inward rectification (Figures 1E and S1D), making
UCP1 uncoupling more effective at physiologically relevant
negative potentials.
Although in the past UCP1 was often postulated to operate as
an H+ channel, IUCP1 was the largest at pH 9.0 and reduced
dramatically when pH was symmetrically (equally in bath and
pipette solutions) decreased to 5.0 (Figure 1H). Based on this
pH dependence, we conclude that UCP1 is unlikely to operate
as a simple H+ channel, for which we would expect higher
current amplitudes at lower pH values. In the experiments pre-
sented below, we seek to clarify themechanism of LCFA-depen-
dent UCP1 operation.402 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.UCP1 Has No Constitutive Activity,
and LCFAs Activate UCP1
Besides LCFAs, other UCP1 activators
have been proposed, most notably long-
chain acyl-CoA (Cannon et al., 1977),
coenzyme Q (ubiquinone, CoQ) (Echtay
et al., 2000), and 4-hydroxy 2-nonenal
(Echtay et al., 2003), but their ability to
activate UCP1 remains controversial
(Jaburek and Garlid, 2003; Nicholls
and Locke, 1984; Shabalina et al., 2006).
In our experiments, 4 mM oleoyl-CoA
strongly inhibited IUCP1 by 92% ± 1% at
160 mV (n = 4; Figure 1G). Coenzyme
Q6 and hydroxy 2-nonenal had no effect
on IUCP1 at 5 mM and 3 mM, respectively
(data not shown). Thus, our data support
the general consensus in the field that
LCFAs are the most likely physiological
activators of UCP1.
Upon breaking-in, we observed robust
IUCP1 in the absence of LCFAs in therecording solutions (Figure 1C), presumably due to the presence
of ‘‘endogenous’’ LCFAs in the IMM. Although 0.25% BSA
added to the bath strongly inhibited this IUCP1, the inhibition
was not complete, as 1 mM GDP caused a further IUCP1 reduc-
tion (Figure S2A). However, 0.5% BSA in both the bath and the
pipette completely inhibited IUCP1, and 1 mMGDP did not cause
any further inhibition (Figure 2A). IUCP1 was also completely
inhibited when both the bath and the pipette solution contained
15 mM aCD (Figure 2B). These experiments indicate that UCP1
has no constitutive activity.
LCFAs were sufficient to activate UCP1. A mixture of LCFAs
with their acceptor methyl-b-cyclodextrin (MbCD) can be used
for fast delivery of LCFAs into the membrane (Brunaldi et al.,
2010). MbCD simultaneously extracts endogenous fatty activa-
tors of UCP1 originally present in the IMM. After deactivation
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Figure 3. Regulation of IUCP1 by Lysopho-
spolipids
(A) Left panel: Representative time course of the
IUCP1 amplitude in control (1), upon the application
of 4 mM oleoyl-lysoPC (2), and the subsequent
application of 1 mM GDP (3). IUCP1 amplitudes
were measured upon stepping from 0 to 160 mV
(see right panel). Right panel: IUCP1 traces re-
corded at times 1, 2, and 3 as indicated in the left
panel.
(B) Left panel: Representative time course of the
IUCP1 amplitude after the extraction of endogenous
LCFAs with 10 mM aCD, reactivation of IUCP1
with 1 mM OA (1), the subsequent addition of
4 mM oleoyl-lysoPC (2), and the application of
1 mM GDP (3). The pipette solution contained
15 mM aCD to extract endogenous membrane
LCFAs. Right panel: IUCP1 traces recorded at times
1, 2, and 3 as indicated in the left panel.
(C) The same experiment as in (A) but performed
with 4 mM oleoyl-lysoPA instead of oleoyl-lysoPC.
(D) The same experiment as in (B) but performed
with 4 mM oleoyl-lysoPA instead of oleoyl-lysoPC.
See also Figure S3.of UCP1 with MbCD, robust IUCP1 was activated by the applica-
tion of 2 mM oleic acid (OA) mixed with 10 mM MbCD (Fig-
ure S2B). Together, these experiments demonstrate that UCP1
has no constitutive activity, and that LCFAs are the likely physi-
ological activators.
LCFAs Are Generated within the IMM
Following the deactivation of IUCP1 by the extraction of endoge-
nous LCFAs using fatty-acid acceptors, a significant fraction of
the IUCP1, recovered as bath aCD (Figure 2C) or BSA (Fig-
ure S2C), was removed. This IUCP1 recovery was strongly pH
dependent, with only a small fraction of the original current
recovered at pH 6.0 (Figure 2D) compared to almost one-halfCell 151, 400–413,at pH 8.0 (Figures 2C and S2D). These
results suggest that an UCP1 activator,
most likely LCFAs, is produced within
the IMM. The smaller IUCP1 recovery at
acidic pH correlates with decreased
activity of mitochondrial PLA2 at a lower
pH (Kinsey et al., 2007; Zurini et al.,
1981). Because Ca2+ in our solutions
was in the low nM range, the putative
PLA2 involved in UCP1 activation must
be Ca2+ independent. At low pH, the low
PLA2 activity (Figure S2D) may contribute
to low IUCP1 amplitudes (Figure 1H).
To further probe the involvement of
PLA2 in UCP1 activation, we tested
the effect of lysophospholipids (PLA2
produces LCFAs and lysophospholipids)
on IUCP1. Given that phosphatidylcholine
and phosphatidylethanolamine are the
two most abundant phospholipids of the
IMM (Osman et al., 2011), lysophosphati-dylcholine (lysoPC) and lysophosphatidylethanolamine (lysoPE)
should suppress IUCP1 activated as a result of PLA2 activity.
Indeed, 4 mM oleoyl-lysoPC or oleoyl-lysoPE inhibited the orig-
inal IUCP1 by 66% ± 1% (n = 3; Figure 3A) and 66% ± 5%
(n = 3; data not shown), respectively. Neither oleoyl-lysoPC nor
oleoyl-lysoPE inhibited UCP1 directly: after the removal of
endogenous LCFAs with aCD, IUCP1 reactivated with exogenous
1 mMOAwas insensitive to 4 mMoleoyl-lysoPC (n = 3; Figure 3B)
or oleoyl-lysoPE (n = 3; data not shown). These experiments
support the conclusion that endogenous membrane LCFAs
generated by PLA2 activate UCP1.
In contrast to lysoPC and lysoPE, which are neutral overall, the
negatively charged lysophosphatidic acid (lysoPA) inhibited bothOctober 12, 2012 ª2012 Elsevier Inc. 403
the original IUCP1 (76% ± 2% inhibition, n = 4; Figure 3C) and
IUCP1 activated by OA (80% ± 1% inhibition, n = 4; Figure 3D).
Thus, lysoPA inhibits UCP1 directly, likely by competing with
structurally related LCFAs for UCP1 binding.
The lipid signaling that controls UCP1 activity in intact cells is
likely more complex than during the whole-mitoplast patch-
clamp. In particular, although PLA2 primarily generates unsatu-
rated LCFAs, mitochondrial phospholipase A1 activity or the
hydrolysis of cytoplasmic lipid droplets can generate saturated
LCFAs in intact cells. Saturated LCFAs interact with lipid
membranes much more strongly than do unsaturated LCFAs
(Anel et al., 1993) and can be ‘‘stuck’’ within the IMM bilayer
unless extracted with BSA or cyclodextrins. These unsaturated
LCFAs can explain the component of the original IUCP1 that never
recovers after the removal of BSA and cyclodextrins (Figures 2C
and 2D). In contrast, the amplitude of the recovered IUCP1 should
be determined only by the equilibrium between the PLA2-depen-
dent production of unsaturated LCFAs and the washout of these
LCFAs from membrane. As the recovered IUCP1 completely
depends on the PLA2 activity, 4 mM lysoPC inhibited the recov-
ered IUCP1 more strongly than the original IUCP1, by 88% ± 2%
(n = 3; Figure S3A). The almost complete inhibition of the recov-
ered IUCP1 by bath lysophospholipids also suggests that the
PLA2 must be located on the cytoplasmic face of the IMM (lyso-
phospholipids cannot flip-flop across the membrane; Bhamidi-
pati and Hamilton, 1995).
We further attempted pharmacological identification of the
Ca2+-independent mitochondrial PLA2 involved in UCP1 activa-
tion. This PLA2 does not belong to the iPLA2 subfamily, as
a selective iPLA2 inhibitor bromoenol lactone (BEL) added into
the bath and/or pipette solution at 50 mM did not affect IUCP1
(n = 4; data not shown). Two newly identified members of the
PLA2 family, cPLA2b and cPLA2g, can also associate with mito-
chondrial membranes in a Ca2+-independent manner (Murakami
et al., 2011). Pyrrophenone and a related compound RSC-3388
inhibit cPLA2b and cPLA2g at micromolar concentrations
(Ghomashchi et al., 2010). Methyl arachidonyl fluorophosphate
(MAFP), a classic inhibitor of Ca2+-dependent cPLA2a, also
inhibits cPLA2g (Stewart et al., 2002). Although 50 mM pyrrophe-
none inhibited the original IUCP1 by 65% ± 6% (n = 5; Figure S3B),
it acted upon UCP1 directly. Indeed, IUCP1 reactivated with 1 mM
of exogenous OA was inhibited 77% ± 3% by 50 mM pyrrophe-
none (n = 3; Figure S3C). Similarly, 50 mM RSC-3388 inhibited
the original IUCP1 by 68% ± 4% (n = 3), and IUCP1 activated by
1 mM OA by 73% ± 3%, (n = 3; data not shown). Finally, 50 mM
MAFP inhibited the original IUCP1 by 47% ± 3% (n = 3) and the
IUCP1 activated by 1 mMOAby 58% ± 6% (n = 3; data not shown).
Thus, although pyrrophenone, RSC-3388, and MAFP inhibit
IUCP1, they act upon UCP1 directly. The identity of the PLA2 iso-
form(s) involved in UCP1 activation remains to be established.
LCFA production within the IMMmay serve as a physiological
mechanism of UCP1 regulation, along with the generation of
LCFAs by the lipolysis of cytoplasmic lipid droplets.
Fatty-Acid Analogs Are UCP1 Transport Substrates
Because LCFAs may serve as H+ carriers in the UCP1 uncou-
pling mechanism (as in the H+ buffering or the fatty-acid cycling
models), we compared IUCP1 induced by regular LCFAs that can404 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.bind H+ at physiological pH and by low-pKa LCFA analogs that
cannot (Jezek and Garlid, 1990; Rial et al., 2004). In solution,
regular LCFAs have a pKa around 4.8, but their pKa after incor-
poration into the phospholipid membrane can increase to 7.5 or
higher, depending on their local membrane (or membrane
protein) environment (Hamilton, 1998). Thus, the majority of
membrane-bound LCFAs are protonated at physiological pH.
In contrast, alkylsulfonates, low-pKa LCFA analogs with
pKaz2 in solution (Guthrie, 1978), are unprotonated at phys-
iological pH even after incorporation into the membrane.
Before activating UCP1 with exogenous fatty acids and their
low-pKa analogs, exogenous membrane LCFAs were extracted
with 10 mM aCD. Experiments were performed in symmetrical
pH 6.0, as at this pH, endogenous LCFAs recover very poorly
after extraction with aCD (Figures 2D and S2D). Under these
conditions, 40 mM lauric acid (C11-carboxylate) activated
a steady H+ IUCP1 in response to the voltage-step protocol
(Figure S4A, right panel), as expected for a regular LCFA. In
a striking contrast, 100 mM undecanesulfonate (C11-sulfonate,
a low-pK analog of lauric acid) induced transient currents in
response to the same voltage-step protocol (Figure S4A, left
panel and Figure 4B, left panel). These transient currents were
carried by UCP1, as they were blocked by GDP (Figure 4B, left
panel) and disappeared in mitoplasts from UCP1/ mice
(Figure S4B).
We next investigated how the length of the hydrophobic tail
affects the IUCP1 induced by alkylsulfonates. Similar to C11-
sulfonate, octadecanesulfonate (C18-sulfonate) induced a
GDP-sensitive transient IUCP1 (Figure 4A, left panel). In contrast,
octanesulfonate (C8-sulfonate) induced a GDP-sensitive IUCP1
with different kinetics, with a time-independent outward current
and a transient inward current (Figure 4C, left panel). Hexanesul-
fonate (C6-sulfonate) induced primarily a time-independent
outward GDP-sensitive IUCP1 with almost no inward current
(Figure 4D, left panel). The currents induced by C8- and C6-
sulfonates completely disappeared in UCP1/ mitoplasts
(Figures S4C and S4D). Generally, the shorter the hydrophobic
carbon tail, the higher the concentration of alkylsulfonate
required to induce IUCP1, with only 10 mMsufficient for C18-sulfo-
nate and 10 mM required for C6-sulfonate (Figures 4A–4D, left
panels). C3-sulfonate failed to induce significant IUCP1, even at
50 mM (Figure 4E, left panel).
IUCP1 induced by alkylsulfonates was not carried by H
+, but by
alkylsulfonates. In particular, the steady current induced by
C6-sulfonate (Figure 4D, left panels) always reversed at the
C6-sulfonate Nernst potentials (Figures 5A and S5), clearly
demonstrating that it was carried by C6-sulfonate and not by H+.
Similarly, the transient IUCP1 induced by C11- and C18-sulfo-
nates (Figures 4A and 4B, left panels) should also be carried
by them. C11- and C18-sulfonates differ from C6-sulfonate
only by their much longer carbon tails that can establish
strong hydrophobic interactions with UCP1 (or the membrane).
Thus, although C11- and C18-sulfonates are transported by
UCP1, they cannot leave the membrane due to the hydrophobic
interactions, resulting in transient currents in response to voltage
steps. Indeed, for the C18-sulfonate current (Figure 4A), the net
charge translocated upon stepping from +50 to 50 mV was
nearly identical to that carried back upon stepping from 50
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the bath (10 mM C18 in A, 100 mM C11 in B, 1 mM C8 in C, 10 mM C6 in D, and 50 mM C3 in E). The calibration bar relates to all traces. A zero current level is
indicated by the green dotted line in (C) and (D). See also Figure S4.
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Error bars represent SEM. See also Figure S5.to +50 mV (the area under the outward transient was only 4% ±
6% larger than under the inward transient; n = 4). For C11-sulfo-
nate, this difference was only 6% ± 3% (n = 4). Although trans-
port of C18- and C11-sulfonates is confined to the membrane,406 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.as expected for permeant species, they inhibited the steady H+
IUCP1 activated by endogenous membrane LCFAs and replaced
it with a transient IUCP1, characteristic of C18- and C11-sulfo-
nates (Figure 5B). C18-sulfonate, with its longer hydrophobic
tail, was a stronger inhibitor than C11-sulfonate (Figure 5B).
Thus, the UCP1 currents carried by C18- and C11-sulfonates
are similar to the gating currents of voltage-gated ion channels
(Bezanilla, 2000) or to pre-steady-state currents observed in
transporters in the presence of only one out of the two trans-
ported charged substrates (Lester et al., 1996; Peres et al.,
2004).
C8-sulfonate was a ‘‘borderline’’ case between the short-
chain C6-sulfonate and the long-chain C11- and C18-sulfonates.
The hydrophobic interactions established by C8-sulfonate are
not strong enough to prevent its steady transmembrane flux
(as indicated by the steady outward current; Figure 4C, left
panel) but are sufficient to keep some C8-sulfonate associated
with UCP1 (or the membrane). This trapped C8-sulfonate is
expelled by application of 50 mV into the mitoplast, causing
the transient inward current (Figure 4C, left panel).
The transient IUCP1 induced by long-chain alkylsulfonates was
not a peculiar property of alkylsulfonates, as the same transient
IUCP1 could be caused by other low-pKa LCFA analogs indepen-
dent of whether pKa-changing modifications were introduced
into the head group or the hydrophobic tail. Perfluorotridecanoic
acid (tail modification; Figure S4E) with a pKa 0 (Goss, 2008)
and dodecyl sulfate (head modification; Figure S4F) with a pKa
3.4 (Guthrie, 1978) caused transient IUCP1.
Thus, similar to other members of the SLC25 superfamily,
UCP1 transports anions. The fact that alkylsulfonates with
shorter hydrophobic tails require higher concentrations for
permeation (Figure 4, left panels) and inhibition of the steady
H+ IUCP1 (Figure 5B) suggests that binding to the fatty-acid anion
translocation site of UCP1 is improved by hydrophobic
interactions.
Because various closely related negatively charged LCFA
analogs (including those with carboxylic heads) are transported
by UCP1, regular LCFA anions should also be UCP1 transport
substrates. Given that LCFAs are required for H+ transport by
UCP1, H+ transport should be coupled to the transport of
LCFA anions. This conclusion is supported by the fact that
long-chain alkylsulfonates inhibit the LCFA-dependent H+
current mediated by UCP1 (Figure 5B) in a competitive manner.
As LCFA anions serve as UCP1 transport substrates, the
purely allosteric UCP1 models (1 and 2 in Figure S1A) cannot
explain the mechanism of UCP1 operation. Our data also do
not support the H+ buffering model (3 in Figure S1A), which
does not explain the transport of fatty-acid anions.
H+ Transport by UCP1 Depends on the pKa
of the Activating LCFA
Because LCFA anions are UCP1 transport substrates, H+ trans-
port by UCP1 is likely to occur as the result of LCFA transport.
Furthermore, H+ transport seems to depend on the ability of
the transported LCFA to bind H+, as in the physiological pH
range, regular LCFAs always activate steady H+ currents,
whereas low-pKa LCFAs are transported alone. If this hypoth-
esis is correct, 1-dibromolauric acid (DBLA), which has a pKa
of 1.3 (Bruce, 2001; Lide, 1998), exactly in-between those of
C11-sulfonate and lauric acid, should be able to activate both
steady H+ and transient DBLA anion currents within the physio-
logical pH range.As we studied IUCP1 induced by DBLA in a broad pH range
(6.0–8.0), we applied DBLA on a background of aCD (3.5 mM
DBLA mixed with 10 mM aCD) to extract the endogenous
membrane LCFAs generated rapidly at high pH and to limit their
effect on UCP1. At pH 6.0, DBLA induced steady IUCP1 (Fig-
ure 5C, upper panel). At pH 7.0, the steady component of IUCP1
was still large, but a clear transient current appeared (Figure 5C,
middle panel). At pH 8.0, almost all IUCP1 induced by DBLA was
transient (Figure 5C, lower panel). This experiment links two
different phenomena, the steady H+ IUCP1 activated by regular
LCFAs and the transient IUCP1 mediated by the low-pKa LCFA
analogs, and shows that both can be observed with a single
LCFA analog. Thus, H+ transport depends on the ability of the
activating LCFA to bind H+: the lower the pKa of the activating
LCFA, the higher the H+ concentration required to observe H+
transport.
The simplest explanation of the observed dependence of H+
transport on the pKa of the activating LCFA is that LCFA anions
directly bind and carry H+ as they are transported by UCP1.
When UCP1 transports LCFA anions, they either move within
UCP1 or through UCP1 from one IMM leaflet to another.
Accordingly, there can be two simple alternative models of
LCFA-dependent H+ transport. In the first model, H+ transport
occurs outside UCP1 by transbilayer LCFA flip-flop, and UCP1
operates in accordance with the fatty-acid cycling model (Fig-
ure S1A). In the second model, H+ is transported through
UCP1 by an LCFA anion shuttling within UCP1 (Figure 7A). We
will call the latter model the ‘‘LCFA-shuttling’’ model to distin-
guish it from the fatty-acid cycling model. Further experiments
demonstrate that UCP1 is unlikely to operate by the fatty-acid
cycling model.
The LCFA-Binding Site Is on the Cytoplasmic Side
of UCP1
As long-chain alkylsulfonates cannot flip-flop across the
membrane, we used them to probe the ability of UCP1 to bind
LCFA anions on different faces of the IMM. Pipette C18- and
C11-sulfonates failed to induce any measurable IUCP1 (Figures
4A and 4B, right panels, red traces); however, as expected, the
subsequent addition of C18- and C11-sulfonates to the bath
solution caused robust transient currents (Figures 4A and 4B,
right panels, blue traces). Only when the pipette concentration
of C11-sulfonate was elevated to 2mM (below the critical micelle
concentration, 20 mM; Annunziata et al., 1999) did C11-sulfo-
nate induce a very small GDP-sensitive transient IUCP1 (Figure 6A,
red trace). The subsequent addition of only 100 mM C11-sulfo-
nate to the bath led to amuch larger IUCP1 (Figure 6A, blue trace).
Thus, UCP1 has a dramatic preference for accepting long-chain
alkylsulfonates on the cytosolic side of the IMM. We used C11-
sulfonate to further investigate this peculiar asymmetry of UCP1.
Adding 10 mM aCD into the pipette significantly altered the
transient IUCP1 inducedby 100 mMbathC11-sulfonate (Figure 4B,
left panel), making the outward current nearly steady and slow-
ing down the kinetics of the inward current (Figure 6B,
upper panel). Obviously, C11-sulfonate tended to abandon the
hydrophobic interactions that anchored it within UCP1 or
the membrane and to move into the pipette to establish hydro-
phobic interactions with aCD. In contrast, the small transientCell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc. 407
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Figure 6. Asymmetry of LCFA Binding to
UCP1
(A) IUCP1 recorded with 2 mM C11-sulfonate in the
pipette. Representative IUCP1 recorded upon
extraction of endogenous membrane LCFAs with
aCD (control, red), in 100 mMC11-sulfonate (blue),
and after the addition of 1 mM GDP (black).
(B) Upper panel: IUCP1 recordedwith 10mM aCD in
the pipette. Representative IUCP1 recorded upon
extraction of endogenous membrane LCFAs with
aCD (control, red), in 100 mMC11-sulfonate (blue),
and after the addition of 1 mM GDP (black). Lower
panel: IUCP1 recorded with 2 mM C11-sulfonate in
the pipette. Representative IUCP1 recorded upon
extraction of endogenous membrane LCFAs with
aCD (control, red), in 10 mM aCD (blue), and after
the addition of 1 mM GDP (black).
(C) Amplitudes of the inward (negative) and
outward (positive) UCP1 currents induced by
various alkylsulfonates added to the bath (blue) or
pipette (red) solutions. IUCP1was recorded with the
same alkylsulfonate concentrations using the
same voltage protocol as in Figures 4A–4D. IUCP1
was measured in the beginning of the second
(50mV, inward IUCP1) and third (+50 mV, outward
IUCP1) voltage steps. The leak current remaining
after application of 1 mM GDP was subtracted.
(D) IUCP1 recordedwith 50mMC6-sulfonate (upper
panel) and 10 mM aCD (lower panel) in the pipette
solution. Representative IUCP1 in 10 mM aCD (red),
in 50 mM C6-sulfonate (blue), and after the addi-
tion of 1 mM GDP (black). The zero current level is
indicated by the dotted line.
(E) I/V curves of IUCP1 induced by1 mMOAat pH 7.0
(black) and pH 8.0 (red). The pipette solution
contained 15 mM aCD, pH 7.0. The IUCP1 ampli-
tudes were measured as indicated in Figure S6B.
(F) The dose dependence of IUCP1 inhibition by ATP
at two different concentrations of activating OA.
IUCP1 was activated either with 0.2 mM OA mixed
with 10 mM MbCD (red curve) or with 2 mM
OA mixed with 10 mM MbCD (black curve).
Amplitudes were measured upon stepping from
0 to 160 mV as in Figures S6C and S6D.
Error bars represent SEM. See also Figure S6.IUCP1 induced by 2 mM pipette C11-sulfonate was unaffected by
the addition of 10 mM aCD to the bath (Figure 6B, lower panel).
These experiments serve as additional evidence for asymmetry
in UCP1 substrate binding and show that the permeation of
matrix C11-sulfonate into UCP1 is very limited and unassisted
by cytosolic aCD.
The access of the matrix C11-sulfonate into UCP1 was not
improved by the presence of a cytosolic substrate (as in the
obligatory exchange mechanism), as the application of cytosolic
lauric acid (C11-carboxylate) did not increase the amplitude of
the transient IUCP1 induced by 2 mM matrix C11-sulfonate but
simply activated steady currents characteristic of lauric acid
(data not shown). Moreover, cytosolic C11- and C18-sulfonates
caused the same amplitude of IUCP1 regardless of the presence
of the same alkylsulfonate on the matrix side of the IMM (Figures
4A, 4B, and 6A), suggesting that the matrix substrate has no408 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.effect on UCP1 function. This supports the conclusion that
UCP1 accepts LCFA anions only on the cytosolic side.
Interestingly, in contrast to long-chain alkylsulfonates, C8- and
C6-sulfonates induced IUCP1 when applied on either side of the
IMM (Figures 4 and 6C). In particular, the application of 50 mM
C6-sulfonate on either the matrix (Figure 6D, upper panel, red
trace) or cytosolic sides (Figure 6D, lower panel, blue trace)
caused about the same amplitude of IUCP1 (see Figure S6A
for statistics). Transport of C6-sulfonate did not occur by the
obligatory exchange mechanism, as C6-sulfonate currents
were recorded in the presence of 10 mM aCD on the opposite
side of the IMM to remove all substrates including endogenous
membrane LCFAs (Figure 6D). On the contrary, when C6-
sulfonate was applied on both sides of the IMM (Figure 6D,
upper panel, blue trace), the amplitudes of the inward and
outward IUCP1 were smaller than those induced by C6-sulfonate
only on one side (Figures 6D and S6A). Thus, C6-sulfonate
permeates through UCP1 from both sides by a channel-like
mechanism.
These experiments with long-tail and short-tail alkylsulfonates
suggest that the long hydrophobic tail prevents the penetration
of matrix alkylsulfonates through UCP1. The small IUCP1
observed with unphysiologically high concentrations of matrix
C11-sulfonate (Figure 6B, lower panel) indicates that at these
high concentrations, the head group can be forced into the
UCP1 translocation pathway from the matrix side; however,
the long hydrophobic tail cannot enter UCP1 from the matrix
side, severely limiting the translocation of the head group and
the current.
The exclusive binding of long-chain substrates to UCP1 from
the cytosolic side argues strongly against the fatty-acid
cycling model because, per this model, UCP1 has to bind and
export matrix LCFAs in order to import H+ into mitochondria
(Figure S1A).
More evidence against the fatty-acid cycling model comes
from measurements of IUCP1 reversal potentials. According to
this model, UCP1 is an LCFA anion carrier, and therefore IUCP1
reversal potentials must depend on the transmembrane concen-
tration gradient of LCFA anions. To establish such a gradient, we
added 15 mM aCD to the pipette solution to deplete LCFA
anions from the inner IMM leaflet and 1 mM OA to the bath solu-
tion to saturate the outer leaflet with OA anions. Under these
conditions, if UCP1 is an LCFA anion carrier, the IUCP1 reversal
potential should be negative, and the IUCP1 amplitude should
be significantly larger in the outward direction. However, the
IUCP1 reversal potential was 0 mV (which corresponds to the
Nernst equilibrium potential for H+ but not for LCFA anions),
and IUCP1 had equal amplitudes in both directions (Figures 6E
and S6B, left panel). In the same experiment, subsequent
elevation of the extracellular pH from 7.0 to 8.0 resulted in a
dramatic 60 mV shift in the IUCP1 reversal potential, as ex-
pected for an H+ current (Figures 6E and S6B, right panel). This
result confirms that UCP1 does not operate in accordance with
the fatty-acid cycling model.
Given that the cytosolic LCFA-binding site of UCP1 and the
strict H+ selectivity are inconsistent with the fatty-acid cycling
model, the simplest model of UCP1 operation that fits all our
experimental data is the LCFA-shuttling model proposed here.
In this model, LCFA anions are UCP1 transport substrates, but
they cannot dissociate from UCP1 due to hydrophobic interac-
tions and serve as permanently attached substrates that shuttle
within UCP1 and help transport H+ (Figure 7A).
LCFAs Can Overcome Purine Nucleotide Inhibition
of UCP1
To activate BAT thermogenesis, LCFAs have to overcome UCP1
inhibition by cytosolic Mg2+-free purine nucleotides (primarily
ATP). However, whether LCFAs remove purine nucleotide
inhibition by direct competition or a different mechanism has
remained controversial (Huang, 2003; Klingenberg, 2010; Nich-
olls, 2006; Rial et al., 1983; Shabalina et al., 2004; Winkler and
Klingenberg, 1994).
To address a possibility of direct competition between LCFAs
and purine nucleotides, we compared the inhibition of IUCP1 byATP at two OA concentrations. To limit the effect of endogenous
membrane LCFAs, OA was applied on a background of 10 mM
MbCD. IUCP1 activated by 0.2 mM OA/10 mM MbCD was
completely inhibited by 100 mM ATP, and 1 mM ATP did not
cause additional inhibition (Figure S6C). In contrast, when IUCP1
was activated by 2 mM OA/10 mMMbCD, 100 mM ATP induced
only moderate inhibition, and 1 mM ATP further suppressed
IUCP1 (Figure S6D). We also compared the dose response of
UCP1 inhibition by ATP under these two OA concentrations.
IUCP1 activated by 0.2 mM OA/10 mM MbCD was inhibited by
ATP with an IC50 of 2.1 ± 0.1 mM, whereas in a 10-fold higher
concentration of OA (2 mM OA/10 mM MbCD), ATP inhibited
IUCP1 with an IC50 of 12.0 ± 2.8 mM (Figure 6F).
Thus, LCFAs have a double effect on UCP1 activation: they
serve as UCP1 transport substrates but can also remove purine
nucleotide inhibition. Because purine nucleotides bind on the
cytosolic side of UCP1, similar to LCFAs, LCFA anions are likely
to directly compete with purine nucleotides.
Cl Conductance of UCP1 Is Negligible as Compared
to Its H+ Conductance
Because UCP1 was also proposed to conduct Cl (Nicholls,
2006), we compared the amplitudes of Cl and H+ currents
through UCP1 to determine whether Cl significantly contributes
to mitochondrial uncoupling.
As compared to the IUCP1 recorded under Cl
-free conditions
(Figure 1B, red trace), the current recorded in symmetrical
150 mM Cl had a larger outward component observed at
the positive voltages (Figure S7A, red trace). This additional
outward current was mediated by large-conductance channels
(100 pS, not shown), as judged by significant step-like fluctua-
tions of the current observed in the positive range of potentials
(Figure S7A, red trace). To smooth out these fluctuations and
simplify the amplitude analysis, all traces were recorded 30–40
times and averaged to obtain the final traces as presented in
Figure S7B.
Addition of 1 mM GDP to the bath led to a dramatic reduction
in the inward current observed at negative membrane potentials,
but the outward current at positive potentials was largely
unaffected (Figures S7A and S7B), suggesting that a significant
portion of the outward current was not UCP1 dependent. Indeed,
recording from UCP1/ mitoplasts in symmetrical 150 mM Cl
revealed a UCP1-independent outward current at positive
membrane potentials (Figures S7C and S7D). This outward Cl
current was likely mediated by the inner membrane anion
channel (IMAC, also called the 108-pS anion channel) (Borecky´
et al., 1997; Jezek et al., 1989) based on its Cl permeability,
outward rectification (conducting current primarily in the
outward direction), and similar single-channel amplitude (around
100 pS).
When we used Mg2+-containing bath and pipette solutions,
the UCP1-independent Cl current was inhibited (Figure S7E,
red trace) as expected for IMAC (Jezek et al., 1989), and we
could study the Cl current through UCP1 only. Under these
conditions, IUCP1 was not significantly affected by the elevation
of Cl in the bath solution from 2 mM to 75 mM (Figure S7E).
However, the reversal potential was slightly shifted by 7 mV,
as determined by the UCP1 I/V relationship (Figure S7F). BasedCell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc. 409
Figure 7. LCFA-Shuttling Model of UCP1
Operation
(A) The simplest mechanism of steady H+ IUCP1
induced by LCFAs. UCP1 operates as a symporter
that transports one LCFA and one H+ per the
transport cycle. First, the LCFA anion binds to
UCP1 on the cytosolic side at the bottom of
a hypothetical cavity (1). H+ binding to UCP1
occurs only after the LCFA anion binds to UCP1
(1). The H+ and the LCFA are translocated by
UCP1 upon conformational change, and H+ is
released on the opposite side of the IMM, whereas
the LCFA anion stays associatedwith UCP1 due to
the hydrophobic interactions established by its
carbon tail (2). The LCFA anion then returns to
initiate another H+ translocation cycle (3). Charge
is translocated only in step 3 when the LCFA anion
returns without the H+.
(B) The mechanism of transient IUCP1 induced by
low-pKa LCFA analogs. A low-pKa LCFA analog
can be translocated by UCP1 similar to an LCFA
anion. However, the low pKa of the LCFA analog
prevents the binding of H+ toUCP1. The negatively
charged low-pKa LCFA analog shuttles within the
UCP1 translocation pathway in response to the
transmembrane voltage, producing transient
currents.
(C) The mechanism of steady IUCP1 induced by
short-chain low-pKa fatty-acid analogs. The
hydrophobic tail is too short to anchor the fatty
analog to UCP1, and the analog is translocated
through UCP1, producing a steady current. In
contrast to LCFAs, the short-chain low-pKa fatty-
acid analogs can bind to UCP1 on both sides of
the IMM.on this shift, we calculated that the UCP1 PCl
/PH
+ permeability
ratio is 43 106, and UCP1 appears to be highly selective for H+
over Cl.
DISCUSSION
LCFAs Are Essential for UCP1 Uncoupling
Despite the agreement that LCFAs activate UCP1, there has
been a controversy as to whether LCFAs are absolutely required
for UCP1 uncoupling or whether UCP1 has some constitutive,
LCFA-independent activity (Garlid et al., 1998; Klingenberg,
2010; Nicholls, 2006). Here we demonstrate under well-
controlled conditions that native UCP1 requires LCFAs for its
H+ transport activity, and that LCFAs serve as permanently
attached UCP1 substrates that help to carry H+ through UCP1.
Wealso show that LCFAs are producedwithin the IMMby a puta-
tive PLA2 associated with the IMM. The ‘‘constitutive’’ LCFA-
independent UCP1 uncoupling observed in ion flux studies in
mitochondria in the presence of albumin (Nicholls, 2006) was410 Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc.likely due to incomplete extraction of
LCFAs produced by mitochondrial PLA2.
The Transport Mechanism of UCP1
The simplest model of UCP1 operation
that explains all our experimental data isthat of an LCFA/H+ symporter, which simultaneously transports
one LCFA anion and one H+ (the LCFA-shuttling model, Fig-
ure 7A). This model assumes that H+ transport is coupled to
LCFA transport but does not necessarily assume direct binding
of H+ to the LCFA anion. Furthermore, although both LCFA and
H+ are UCP1 transport substrates, LCFA cannot dissociate
fromUCP1, andUCP1 operates as a virtual H+ carrier (Figure 7A).
Although in accordancewith thismodel, H+ is transported across
the membrane, the symport of H+ in association with LCFA is
electroneutral. The charge translocation (the UCP1 current) is
produced by the head group of the LCFA anion when, after
releasing H+, it returns to the opposite side of the membrane
(Figure 7A). Thus, although the steady currents carried by
UCP1 are termed ‘‘H+ currents’’ due to the fact that they reverse
at the Nernst potentials for H+ (Figure 1F), in accordance with our
model, these currents are actually carried by the shuttling LCFA
anions. Although the model presented in Figure 7A shows H+
transport only in one direction, that transport is fully reversible:
H+ can bind to UCP1 on both sides of the IMM, and UCP1 can
transport H+ in both directions. The LCFA-shuttling model corre-
lates well with the prediction (based on symmetry analysis of
SLC25 members) that UCP1 transports carboxylic or keto acids
in symport with H+ (Robinson et al., 2008).
LCFA anions appear to act as the ‘‘principal’’ UCP1 substrate,
as they can be transported by UCP1 independent of H+ trans-
port. H+ appears to be a ‘‘secondary’’ UCP1 substrate because
H+ transport by UCP1 depends on LCFAs and their pKa.
Low-pKa LCFA analogs are transported by UCP1 alone,
without H+. They cannot dissociate from UCP1 due to hydro-
phobic interactions and shuttle back and forth within UCP1 as
the membrane potential changes, resulting in transient UCP1
currents (Figure 7B). In contrast, short-chain low-pKa fatty-
acid analogs do not establish strong hydrophobic interactions
and can dissociate from UCP1, producing actual transmem-
brane currents (Figure 7C).
The LCFA-shuttling model can explain the peculiar pH depen-
dence of IUCP1 (Figure 1H). According to the LCFA-shuttling
model (Figure 7A), the H+ current carried by UCP1 will be small
either at very high symmetrical pH or very low symmetrical pH.
At high pH, there are no H+ to be transported, and at low pH,
H+ cannot dissociate from UCP1, and both the LCFA anion
and H+ remain associated with UCP1, resulting in electroneutral
transport. Thus, the pH dependence of IUCP1 should be bell-
shaped, with the maximum around the pKa of the H+-binding
site of UCP1. This pKa for H+ transport depends on the pKa of
the cotransported LCFA anion. For the IUCP1 activated by regular
LCFAs, the pKa for H+ transport appears to be around 8.0–9.0,
and therefore, at our experimental pH (5.0–9.0), we observed
only the left wing of the bell-shaped pH dependence of the H+
current (Figure 1H). However, for IUCP1 activated by DBLA (pKa
is 3.5 units lower than that of regular LCFAs), we likely observed
the right wing of the pH dependence, as at pH 8.0, UCP1
primarily carried transient currents mediated by LCFA anions
and very little steady H+ current (Figure 5C). In addition to the
pH dependence of the UCP1-binding site for H+ transport, the
pH dependence of LCFA production within the IMM (Figure S2D)
should also contribute to the overall pH dependence of IUCP1.
UCP1 is an anion carrier; however, based on our data, the
transported anion must possess a hydrophobic tail, and as the
length of this tail decreases, the affinity of the alkyl anion for
the substrate-binding site of UCP drops significantly (Figure 4A).
The importance of the hydrophobic tail for anion permeation
through UCP1 has been previously suggested (Jezek and Garlid,
1990). Therefore, although UCP1 can in principle transport Cl
(Nicholls, 2006), we showed that the Cl current through UCP1
is small in comparison with the currents produced by LCFA
analogs/H+, and that Cl is unlikely to contribute significantly
to UCP1 uncoupling.
The LCFA-shuttling model bears similarities to the recently
proposed mechanism of operation of CLC H+/Cl exchangers
(Feng et al., 2010). In these proteins, the transport of H+ is medi-
ated by the carboxylic group of a glutamate residue (the so-
called gating glutamate) that shuttles along the channel-like
anion translocation pathway.
It is important to understand that the transport mechanism in
Figure 7 represents the simplest model that fits our data. Further
experiments are required to clarify the exact stoichiometry oftransport, binding sites of for H+ and LCFAs, and the conforma-
tional change that leads to the translocation of LCFA and H+.
The Role of LCFAs in the Removal of Purine Nucleotide
Inhibition of UCP1
In living cells, UCP1 is tonically inhibited by purine nucleotides,
primarily ATP. Purine nucleotides bind on the cytosolic side of
UCP1 and seem to occlude the UCP1 translocation pathway
(Klingenberg, 2010). The identity of the molecule that overcomes
ATP inhibition and helps to activate UCP1 uncoupling in BAT has
remained elusive. Two primary candidates, LCFAs and long-
chain acyl-CoA, have been suggested but remain controversial
(Huang, 2003; Rial et al., 1983; Shabalina et al., 2004; Winkler
and Klingenberg, 1994). In our experiments, LCFAs were able
to overcome the inhibition of UCP1 by ATP4 (Figure 6F),
whereas long-chain acyl-CoA (similar to related purine nucleo-
tides) was a potent UCP1 inhibitor (Figure 1G).
LCFA anions are permeable species and in principle can
directly compete with ATP4 that binds near or within the trans-
location pathway. Due to the significant structural differences
between LCFA anions and ATP4, their binding sites on UCP1
cannot be identical but may partially overlap, so that the electro-
static repulsion between the two negatively charged ligands
results in competition. Although LCFAs can overcome ATP inhi-
bition in patch-clamp experiments, the validity of this mecha-
nism for the removal of UCP1 inhibition by ATP in intact brown
adipocytes remains to be established.
EXPERIMENTAL PROCEDURES
Isolation of BAT Mitochondria and Mitoplasts
Mice (3–4 weeks old) were sacrificed by CO2 asphyxiation followed by cervical
dislocation. Interscapular BAT was isolated, and mitochondria were isolated
as in Kirichok et al. (2004). Mitoplasts (vesicles of the whole native IMM)
were produced frommitochondria using a French press at 2,000 psi to rupture
the outer membrane, which allows for gentle and pure mechanical isolation of
mitoplasts (Decker and Greenawalt, 1977).
Immediately before the electrophysiological experiments, 15–50 ml of the
mitoplast suspension was added to 500 ml solution containing 150 mM KCl,
10 mM HEPES, and 1 mM EGTA (pH adjusted to 7.2 with KOH) and plated
on 5 mm coverslips. For whole-mitoplast experiments, coverslips were pre-
treated with 0.1% gelatin to reduce adhesion, whereas untreated coverslips
were used for outside-out experiments. Only mitoplasts that had a dense,
opaque matrix were selected for experiments, as this indicated the integrity
of their matrix and thus their membranes.
Patch-Clamp Recordings
Mitoplasts used for patch-clamp experiments were 3–5 mm in diameter and
typically had membrane capacitances of 0.5–1.2 pF. Gigaohm seals were
formed in the bath solution containing 150 mM KCl, 10 mM HEPES, and
1 mM EGTA, pH 7.2 (adjusted with KOH). A 3 M KCl agar salt bridge was
used as the bath reference electrode. Voltage steps of 250–800 mV and
1–50 ms were applied to obtain the whole-mitoplast configuration, as
monitored by the appearance of capacitance transients. The access resis-
tance and membrane capacitance of mitoplasts were determined with the
Membrane Test tool of pClamp 10 (Molecular Devices). Mitoplasts were
stimulated every 5 s.
At very negative membrane potentials, whole-mitoplast IUCP1 showed
a time-dependent reduction in amplitude (see, for example, Figure S1D) due
to saturation of the H+ buffer inside the mitoplast. To reduce experimental
errors associated with such saturation, we measured amplitudes of whole-
mitoplast IUCP1 at the beginning of the voltage steps and set the holding
voltage at the H+ reversal potential whenever appropriate.Cell 151, 400–413, October 12, 2012 ª2012 Elsevier Inc. 411
For the experiments shown in Figures 1, 2, 3, 4A–4D, 5, 6A–6C, 6D (lower
panel), 6F, S1, S2, S3, S4, S5,and S6B–S6D, pipettes were filled with
150 mM tetramethylammonium hydroxide (TMA), 1.5 mM EGTA, 1–2 mM
magnesium gluconate, 150 mM HEPES (MES or CHES), and 2 mM Tris-Cl
(pH adjusted to 5.0–9.0 with D-gluconic acid, tonicity adjusted to
450 mmol/kg with sucrose). In experiments that required 50 mM hexanesul-
fonate (C6-sulfonate) or 50 mM propanesulfonate (C3-sulfonate) on the matrix
side of the IMM as shown in Figures 4E, 6D (upper panel), and S6A, we used
the following pipette solution: 100 mM TMA, 1.5 mM EGTA, 1 mMmagnesium
gluconate, 100 mM MES, 50 mM sodium hexanesulfonate (or propanesulfo-
nate), and 2 mM Tris-Cl (pH adjusted to 6.0 with D-gluconic acid, tonicity
adjusted to 450 mmol/kg with sucrose). Typically, pipettes had resistances
of 25–40 MU, and the access resistance was 40–75 MU. The calculated
voltage-clamp error associated with the access resistance did not exceed
10 mV.
Whole-mitoplast IUCP1 were recorded in the bath solution containing
150 mM HEPES (or MES or CHES) and 1 mM EGTA (pH adjusted to 5.0–9.0
with D-gluconic acid or Tris base, tonicity adjusted to 300 mmol/kg with
sucrose). In some instances, 2 mM magnesium gluconate was added to the
bath solution to improve membrane stability, which did not change IUCP1
behavior. In experiments requiring 50 mM hexanesulfonate (C6-sulfonate) or
50 mM propanesulfonate (C3-sulfonate) on the cytosolic side of the IMM as
shown in Figures 4E, 5A, 6C, 6D, S5, and S6A, we used the following bath
solution: 100mMMES, 50mMsodium hexanesulfonate (or propanesulfonate),
and 1 mM EGTA (pH adjusted to 5.0–9.0 with D-gluconic acid or Tris base,
tonicity adjusted to 300 mmol/kg with sucrose). All experiments were per-
formed under continuous perfusion of the bath solution.
To record whole-mitoplast Cl currents (Figures S7A–S7D), we used
a pipette solution containing 150 mM CsCl, 150 mM HEPES, and 1 mM
EGTA (pH adjusted to 7.0 with Tris base, tonicity adjusted to 450 mmol/kg).
The bath solution in these experiments contained 150 mM Tris-Cl, 20 mM
HEPES, and 1 mM EGTA (pH adjusted to 7.0 with Tris base, tonicity
300mmol/kg with sucrose). In experiments investigating the relative selectivity
of UCP1 for Cl versus H+ (Figures S7E and S7D), we used symmetrical bath/
pipette solutions that contained 100 mM CsOH, 1 mM Mg gluconate, 1.5 mM
EGTA, 150 mM HEPES, and 2 mM Tris-Cl (pH adjusted to 7.0 with D-gluconic
acid, tonicity adjusted to 300 mmol/kg with sucrose). The 75 mM Cl bath
solution in these experiments contained 75 mM HCl, 100 mM CsOH, 1 mM
Mg gluconate, 1.5 mM EGTA, 150 mMHEPES, and 2 mM Tris-Cl (pH adjusted
to 7.0 with Tris base, tonicity adjusted to 300 mmol/kg with sucrose).
Membrane potentials were corrected for the liquid junction potential in exper-
iments probing the relative selectivity of UCP1 for Cl versus H+.
Data acquisition and analysis were performed using PClamp 10 (Molecular
Devices) and Origin 7.5 (OriginLab). All electrophysiological data presented
were acquired at 10 kHz and filtered at 1 kHz. Statistical data are presented
as the mean ± standard error of the mean (SEM).
All general chemicals including fatty acids and their low-pKa analogs were
acquired from Sigma (St. Louis, MO, USA). Phospholipase A2 inhibitors and
1-dibromolauric acid were from Cayman Chemical Company (Ann Arbor, MI,
USA). Lysophospholipids and acyl-CoA were from Avanti Polar Lipids and
Sigma. DBLA was synthesized by Cayman Chemical Company.
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